Key facts
- This page summarizes Fu-Feng Kuo's Form 3 filing for Jyong Biotech Ltd. (MENS).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Apr 2026, 10:11.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
25,349,500 ordinary shares are held by Perfect Minds Co., Ltd., a Seychelles company ("Perfect Minds"), which is wholly owned by Innovation Global Group Limited, a British Virgin Islands company, which is wholly owned by The Innovation Trust, a discretionary trust, (the "Trust"). The Trust is managed by Unity Trust Limited, as the trustee. Ms. Fu-Feng Kuo is the Settlor, Appointor and one of the eligible beneficiaries of the Trust. Ms. Fu-Feng Kuo is also the sole director of Perfect Minds and has sole voting and sole dispositive power over the 25,349,500 ordinary shares by virtue of her authority to direct voting and investment decisions with respect to the securities held by Perfect Minds. Accordingly, Ms. Fu-Feng Kuo may be deemed to beneficially own 25,349,500 ordinary shares.